ZoomMed inc.
TSX VENTURE : ZMD
TSX CROISSANCE : ZMD

ZoomMed inc.

February 28, 2006 23:59 ET

ZoomMed announces the third closing of an offering

MONTREAL, Feb. 28 - ZoomMed inc. ("ZoomMed") (TSX VentureExchange: ZMD)
announces that, on February 28, 2006, pursuant to an amended
prospectus dated December 20, 2005, it completed a third closing resulting in
the issuance of 3,739,200 common shares of ZoomMed, at a price of $0.20 per
share. The gross proceeds resulting from the issuance of these shares are
$747,840.

In connection with this offering of shares, ZoomMed has paid to Versant
Partners Inc. ("Versant"), the agent, a cash commission, and has issued to
Versant, as remuneration, warrants entitling it to purchase 186,960 common
shares of ZoomMed, at a price of $0.20 per share, for a period of 18 months.

Pursuant to the amended prospectus dated December 20, 2005, the
corporation issued, to date, a total of 9,090,700 common shares of its share
capital for total gross proceeds of $1,818,140.

ZoomMed is presently developing a new electronic tool "ZRx Prescriber",
intended to change the way drugs are prescribed and dispensed throughout
Canada. This handheld prescribing system device, equipped with tools such as a
therapeutic advisor as well as a medication interaction manager, will enable
doctors to fill prescriptions and to electronically transmit them in a fast
and secure mode. This user friendly Web product, designed for doctors, will
use the latest "Pocket PC" technologies.

The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.

Contact Information

  • Yves Marmet
    President and Chief Executive
    Officer
    (450) 678-5457